Lifetime attributable risk as an alternative to effective dose to describe the risk of cancer for patients in diagnostic and therapeutic nuclear medicine

Most recent

• Librarian spotlight: An interview with Tuba Akbayturk
• Librarian Spotlight: An interview with Ertuğrul Çimen
• From academia to publishing: career journeys at IOP Publishing
• New scientific method can now tell real Van Goghs from fakes
• Supporting families and carers at IOP Publishing